वाराणसी के BHU में रिसर्च; बिना बायोप्सी के प्रोस्टेट कैंसर की होगी सटीक पहचान, 24 घंटे में मिलेगी रिपोर्ट

ETVBHARAT

काशी हिंदू विश्वविद्यालय की महिला वैज्ञानिक डॉ. गरिमा जैन ने किया एक बड़ा रिसर्च.

Transcript

00:00Cancer T klaranct ke liye, biopsi karana bhehad jab rota hai.

00:04Laughab 80-30 thdhi alag alag tarikhi ke cancer ke liye baiopsi jarrori maanit jatai hai.

00:09Baiopsi karanay meine jahan lamba wakt ligta hai,

00:12to, vahhin lambbuilding khach ke satt hhi marijo ko entgozar bhi karna page traita hai.

00:16Leekin ab mehajik bio marker ki ze rariye hir prostate cancer ka pata chal sakega,

00:22This is a new research for prostate cancer, which has been given to me in terms of cancer.

00:39He told us that this is a new research for prostate cancer.

00:45the result in 20 days.

00:48It was about 25,000 Rs.

00:51But in the past,

00:54the patient's 24 hours

00:57can be found in the case of cancer.

01:00It is a prostate gland

01:04which is a part of the male's urinogenital organ system.

01:08This is an age-related disease.

01:11Generally, it is seen in 70-plus patients.

01:15But in some cases,

01:18the cases of prostate cancer

01:19have been increased in the last 5 years

01:22according to the recent cancer data.

01:25And the age of origin

01:30which was already 70-plus,

01:32now it is also going down around 55-plus.

01:35So we have patients

01:37who are in the age range

01:39and have prostate cancer.

01:40So the age is reduced

01:42and the number of cases is increased.

01:44In prostate cancer,

01:46we have made a liquid biopsy-based test

01:48in which we use a blood sample

01:50with RNA biomarkers

01:52to use prostate cancer

01:54or benign prostate growth.

01:56We differentiate them.

01:58Now, prostate cancer's diagnosis pipeline

02:01that the patient will do

02:03MRI, DR, and then biopsy

02:06and then biopsy

02:07in which we get 20-25 days

02:08will be lost.

02:09But if there is a malignancy

02:12or not,

02:13we can only know about biopsy.

02:15There is no other tool

02:16to know about malignancy.

02:18Biopsy is an invasive procedure.

02:20We have removed a liquid biopsy test

02:22and we have removed a liquid biopsy test

02:24which we have removed from blood.

02:26This research

02:28has started in 2022.

02:30Now, we have completed pre-clinical trial

02:32and completed

02:33which has 88% accuracy achieved.

02:36After 2 years,

02:38we have complete research

02:39after 2 years

02:40and will be able to develop

02:41the clinical trial

02:42and after 2 years

02:43this test is available

02:45on the market

02:46and if this test is available

02:48with blood test

02:49it will be able to know

02:51that it will be cancer

02:53in the next two months.

02:54This time is over

02:55and the time is over

02:56and the time is over

02:57and we have been recording

02:58in the 24 hours.

02:59The report is over

03:01because,

03:02it will be unnecessary biopsy

03:04which are benign, they are also doing biopsy because there is no other way to put it.

03:10The patient's cost is currently 20-25,000.

03:15We are currently doing 3,000-3,000 in our test.

03:20If the patient gets cured, they will quickly know that the cancer is in the early stage,

03:27in the early stage, and in the early stage, we work accurately accurately.

03:31We have now done 125 patients, which has 90% accuracy achieved.

03:37We are doing this research globally.

03:41In fact, many tests are available in America and Europe.

03:45But in India, we do not have any tests in the market.

03:48The research has not been extensively in the Indian population.

03:53The most key biomarker of prostate cancer is PSA.

04:00But PSA-4 is not related to prostate cancer.

04:06We do not relate to prostate cancer.

04:09If PSA-4 is on the top of prostate cancer,

04:12then you can indicate any type of prostate cancer.

04:16The baby is being removed from the body.

04:17The same as the cancer is in the top of prostate cancer.

04:19The patient is being removed from the top of prostate cancer.

04:21foreign

04:28foreign

04:33foreign

04:42foreign

Category

Transcript

Recommended